Unlocking the Full Potential of Adaptive Radiotherapy

Imagine a world where every cancer patient has access to life-saving radiation therapy.

Adaptive Radiotherapy (ART) ensures treatment plans stay aligned with a patient's changing anatomy. However, widespread adoption remains a challenge—ART is traditionally expensive, resource-intensive, and requires specialized equipment, advanced software, and significant clinical oversight. Identifying and executing a replan can take hours or even days, delaying critical treatment.

Replans are often identified ad hoc, requiring:

• Detecting discrepancies in daily treatment imaging scans
• Escalating for investigation
• Importing data into multiple systems for evaluation
• Qualitatively Comparing daily treatment scans with planning scans
• Re-scan the patient if daily treatment scans are poor quality
• Contour critical anatomy on daily scans and compare to planning anatomy
• Quantitatively compare treatment dose across daily and planning data
• Compiling findings for radiation oncologist review
• Decision-making on whether to replan

Mid-treatment replans (e.g. at fraction 15) follow a time-consuming workflow:

• Scheduling and performing a re-planning scan
• Re-plan dose on the new scan and contours
• Radiation oncologist determining if the new plan should be adopted

Every step adds delays, drains resources, and slows the path to optimal patient care.

Imagine if you didn't need to wait for a new sim and new plan to confirm whether a replan is necessary. Imagine if all decision-making data was automatically available for every patient, for every treatment fraction.

The Solution: Automate, Accelerate, Treat More Patients

Imagine if we could revolutionize this process

• Automatically generate comparative dosimetric analytics from every patient's daily treatment scan
• Instantly flag deviations in treatment volumes or organs at risk
• Put all replan decision data at every clinician's fingertips - instantly

At SeeTreat, we're making this vision a reality. Our goal is to bring automated, scalable, and accessible Adaptive Radiotherapy to the world—allowing more cancer patients to get the treatment they need, exactly when they need it.